We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant
WGSWW

Delisted

WGSWW was delisted on the 21st of July, 2026.

Back to rankings

27 hedge funds and large institutions have $3.74M invested in GeneDx Holdings Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 27 → 27 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

57% less capital invested

Capital invested by funds: $8.77M → $3.74M (-$5.02M)

Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
6
Closed
1
Calls
$70K
Puts
–
Net Calls
+$70K
Net Calls Change
-$129K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$30.4K
2
OMC
Old Mission Capital
Illinois
+$6.09K
3
GS
Gagnon Securities
New York
+$2.07K
4
WAM
Wolverine Asset Management
Illinois
+$1.22K
5
Jane Street
Jane Street
New York
+$42

Top Sellers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
-$35K
2
LP
LMR Partners
United Kingdom
-$13.7K
3
AGM
Alpine Global Management
New York
-$7.83K
4
IM
Islet Management
New York
-$6.46K
5
HF
HRT Financial
New York
-$1.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$2.07M -$13.7K -33,667 -2%
ICM
2
Ionic Capital Management
New York
$417K -$989 -2,425 -0.2%
Blackstone Inc
3
Blackstone Inc
New York
$231K – – –
GS
4
Gagnon Securities
New York
$216K +$2.07K +5,082 +0.8%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$162K – – –
DCM
6
Difesa Capital Management
New York
$138K – – –
BCP
7
Berylson Capital Partners
Massachusetts
$108K – – –
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$97K – -1 -0%
GA
9
Gagnon Advisors
New York
$80K – – –
IM
10
Islet Management
New York
$63K -$6.46K -15,857 -8%
MP
11
MSD Partners
New York
$33K – – –
WAM
12
Weiss Asset Management
Massachusetts
$32K – – –
UBS Group
13
UBS Group
Switzerland
$25K +$30.4K +74,627 +5,197%
Wellington Management Group
14
Wellington Management Group
Massachusetts
$21K – – –
SAMU
15
SONA Asset Management (US)
New York
$10K – – –
HF
16
HRT Financial
New York
$9K -$1.34K -3,289 -10%
AGM
17
Alpine Global Management
New York
$7K -$7.83K -19,200 -48%
TD Asset Management
18
TD Asset Management
Ontario, Canada
$6K – – –
OMC
19
Old Mission Capital
Illinois
$5K +$6.09K +14,949 New
Brown Advisory
20
Brown Advisory
Maryland
$4K – – –
Jane Street
21
Jane Street
New York
$4K +$42 +103 +0.8%
WAM
22
Wolverine Asset Management
Illinois
$4K +$1.22K +3,000 +28%
DCM
23
Dupont Capital Management
Delaware
$2K – – –
Wells Fargo
24
Wells Fargo
California
$1K – – –
MF
25
Magnetar Financial
Illinois
$10 – – –
1
2

WGSWW Hedge Fund Activity: Q2 2022 in Review

27 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2022, worth a combined $3.74M — down 57% from $8.77M a quarter earlier.

Fund positioning in WGSWW was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 6 trimmed.

The largest buyer was UBS Group, adding an estimated $30.4K. The largest seller was Aristeia Capital, exiting entirely with an estimated $35K sold.

  • 27 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $3.74M of GeneDx Holdings Warrant stock for Q2 2022, down 57% quarter-over-quarter.
  • 1 fund opened new GeneDx Holdings Warrant positions in Q2 2022 and 1 closed out, a net change of 0 holders.
  • The largest GeneDx Holdings Warrant buyer in Q2 2022 was UBS Group, an estimated $30.4K added.
  • The largest GeneDx Holdings Warrant seller in Q2 2022 was Aristeia Capital, an estimated $35K sold.

Based on aggregated 13F filings for Q2 2022.